Tristan Knight - Concepedia

Author

Tristan Knight

Wayne State University ORCID

Also Known As

Knight T, T Knight, T. Knight, Tristan E Knight, Tristan E. Knight, Tristan Knight

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Wayne State University Children's Hospital of Michigan The Barbara Ann Karmanos Cancer Institute Jilin University First Hospital of Jilin University

About

Tristan Knight is an author at Wayne State University specializing in medicine, immunology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	112
2	Immunology	3	3	94
3	Health Sciences	2	2	42
4	Biology	1	1	18
5	Cell Biology	1	1	52

Tristan Knight

Publications

692

Citations

H-Index

Page 1

	Year	Citations
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome Melissa Hines, Tristan Knight, Kevin O. McNerney, Transplantation and Cellular Therapy	2023	264
Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia Jun Ma, Xinan Qiao, Tristan Knight, Clinical Cancer Research	2019	172
Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia Xinyu Li, Yongwei Su, Gerard J. Madlambayan, Haematologica	2019	65
The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia Xinyu Li, Yongwei Su, Katie Hege, Haematologica Mixed-phenotype Acute LeukemiaImmunologyCell DeathMyeloid NeoplasiaHematological Malignancy	2020	52
The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML Xinan Qiao, Jun Ma, Tristan Knight, Blood Cancer Journal	2021	39
<p>Evaluating venetoclax and its potential in treatment-na&iuml;ve acute myeloid leukemia</p> Tristan Knight, Holly Edwards, Jeffrey W. Taub, Cancer Management and Research Evaluating VenetoclaxMixed-phenotype Acute LeukemiaImmunologyPathologyPharmacotherapy	2019	30
Chimeric Antigen Receptor T-Cell Therapy in the Outpatient Setting: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy Olalekan O. Oluwole, Bhagirathbhai Dholaria, Tristan Knight, Transplantation and Cellular Therapy	2023	21
Mild erythrocytosis as a presenting manifestation of<i>PIEZO1</i>associated erythrocyte volume disorders Tristan Knight, Ahmar U. Zaidi, Sheng-Nan Wu, Pediatric Hematology and Oncology	2019	19
In vivo effects of oxytocin on the contractile activity of the cannulated epididymis and vas deferens in rams Tristan Knight Reproduction Animal PhysiologyBiologyPhysiologyCannulated EpididymisVas Deferens	1972	18
Successful Treatment of an Adolescent Male With Severe Refractory Evans Syndrome Using Bortezomib-based Therapy Tristan Knight, Yaddanapudi Ravindranath, Michael U. Callaghan Journal of Pediatric Hematology/Oncology Successful TreatmentImmunologyPathologyImmunotherapyAdolescent Male	2018	12

Page 1